Low serum zinc levels in an endemic area of visceral leishmaniasis in Bihar, India

Indian Journal of Medical Research

Volumn 131, Issue 6, 2010, Pages 793-798

  Mishra, Jyotsna ^a   Carpenter, Stephen ^b   Singh, Sarman ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bihar socio economic status; Epidemiology; Immune system; Malnourishment; Visceral leishmaniasis; Zinc deficiency

Indexed keywords

PLASMA PROTEIN; SERUM ALBUMIN; ZINC;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; COLORIMETRY; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENDEMIC DISEASE; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; VENOUS BLOOD; VISCERAL LEISHMANIASIS; ZINC BLOOD LEVEL; ANIMAL; BLOOD; CHILD; LEISHMANIA; POVERTY; RURAL POPULATION; URBAN POPULATION;

ADULT; ANIMALS; CHILD; FEMALE; HUMANS; INDIA; LEISHMANIA; LEISHMANIASIS, VISCERAL; MALE; POVERTY; RURAL POPULATION; URBAN POPULATION; YOUNG ADULT; ZINC;

EID: 77953337570     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002; 2: 494-501.
2. Sivakumar R, Sharma P, Chang KP, Singh S. Cloning, expression, and purification of a novel recombinant antigen from Leishmania donovani. Protein Expr Purif 2006; 46: 156-65.
3. Sivakumar R, Dey A, Sharma P, Singh S. Expression and characterization of a recombinant kinesin antigen from an old Indian strain (DD8) of Leishmania donovani and comparing it with a commercially available antigen from a newly isolated (KE16) strain of L. donovani. Infect Genet Evol 2008; 8: 313-22.
4. Singh S, Kumar J, Singh R, Dwivedi SN. Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study. Int J Infect Dis 2000; 4: 203-8.
5. Das M. Health in Bihar - an overview. Health Millions 1999; 25: 21-3.
6. Sharma U, Singh S. Immunobiology of leishmaniasis. Indian J Exp Biol 2009; 47: 412-23.
7. Alvar J, Canavate C, Gutierrez-Solar B, Jimenez M, Laguna F, Lopez-Velez R, et al. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clin Microbiol Rev 1997; 10: 298-319.
8. Revillard JP, Cozon G. Experimental models and mechanisms of immune deficiencies of nutritional origin. Food Addit Contam 1990; 7 (Suppl 1): S82-6.
9. Harrison LH, Naidu TG, Drew JS, de Alencar JE, Pearson RD. Reciprocal relationships between undernutrition and the parasitic disease visceral leishmaniasis. Rev Infect Dis 1986; 8: 447-53.
10. Saha S, Mondal S, Banerjee A, Ghose J, Bhowmick S, Ali N. Immune responses in kala-azar. Indian J Med Res 2006; 123: 245-66.
11. Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13: 151-77.
12. Sprietsma JE. Zinc-controlled Th1/Th2 switch significantly determines development of diseases. Med Hypotheses 1997; 49: 1-14.
13. Wirth JJ, Fraker PJ, Kierszenbaum F. Zinc requirement for macrophage function: effect of zinc deficiency on uptake and killing of a protozoan parasite. Immunology 1989; 68: 114-9.
14. Fraker PJ, Caruso R, Kierszenbaum F. Alteration of the immune and nutritional status of mice by synergy between zinc deficiency and infection with Trypanosoma cruzi. J Nutr 1982; 112: 1224-9.
15. Redhu NS, Dey A, Balooni V, Singh S. Use of immunoglobulin G avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients. Clin Vaccine Immunol 2006; 13: 969-71.
16. Makino T. A simple and sensitive colorimetric assay of zinc in serum using cationic porphyrin. Clin Chim Acta 1999; 282: 65-76.
17. Singh S, Sivakumar R. Challenges and new discoveries in the treatment of leishmaniasis. J Infect Chemother 2004; 10: 307-15.
18. Singh MV, Singh AP, Maji AK. Zinc fertility status in soils of Bihar. In: Singh MV, editor. Micronutrients fertility mapping for Indian soils. Tech Bulletin AICRP, Micronutrients, Report No. 7. Bhopal: Indian Institute of Soil Science (ICAR); 2008. p. 1-60.
19. Thakur CP. Socio-economics of visceral leishmaniasis in Bihar (India). Trans R Soc Trop Med Hyg 2000; 94: 156-7.
20. Bern C, Haque R, Chowdhury R, Ali M, Kurkjian KM, Vaz L, et al. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. Am J Trop Med Hyg 2007; 76: 909-14.
21. Bogden JD, Kemp FW, Han S, Li W, Bruening K, Denny T, et al. Status of selected nutrients and progression of human immunodeficiency virus type 1 infection. Am J Clin Nutr 2000; 72: 809-15.
22. Bao B, Prasad AS, Beck FW, Godmere M. Zinc modulates mRNA levels of cytokines. Am J Physiol Endocrinol Metab 2003; 285: E1095-1102.
23. Van Weyenbergh J, Santana G, D'Oliveira A, Jr, Santos AF, Jr, Costa CH, Carvalho EM, et al. Zinc/copper imbalance reflects immune dysfunction in human leishmaniasis: an ex vivo and in vitro study. BMC Infect Dis 2004; 4: 50.
24. Pasa S, Kargin F, Bildik A, Seyrek K, Ozbel Y, Ozensoy S. Serum and hair levels of zinc and other elements in dogs with visceral leishmaniasis. Biol Trace Elem Res 2003; 94: 141-7.
25. Faryadi M, Mohebali M. Alterations in serum zinc, copper, and iron concentrations in patients with acute and chronic cutaneous leishmaniasis. Iran J Public Health 2003; 32: 53-8.
26. Ribeiro-de-Jesus A, Almeida RP, Lessa H, Bacellar O, Carvalho EM. Cytokine profile and pathology in human leishmaniasis. Braz J Med Biol Res 1998; 31: 143-8.
27. Rocha PN, Almeida RP, Bacellar O, de Jesus AR, Filho DC, Filho AC, et al. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis. J Infect Dis 1999; 180: 1731-4.
28. Al-Gurairi FT, Al-Waiz M, Sharquie KE. Oral zinc sulphate in the treatment of recalcitrant viral warts: randomized placebo-controlled clinical trial. Br J Dermatol 2002; 146: 423-31.
29. Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ. Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 2001; 26: 21-6.